StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27−0.09 (-25.05%)

Close on Nov 17, 2026Market cap $2.88MP/E –Yield –

Gelteq r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was A$628.61K, up 127.7% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$628.61K+127.7%
FY2024Jun 30, 2024A$276.06K-58.5%
FY2023Jun 30, 2023A$665.04K–

More Gelteq figures

See a number that looks wrong?